Moderna says trials show its COVID-19 vaccine is effective in kids as young as 12

Moderna said Tuesday that Phase 2 trial results show that its COVID-19 vaccine is effective in adolescents aged 12 to 17.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting